Avestar Capital’s Labcorp LH Stock Holding History

Avestar Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15	Closed	-$1K	–	544
2019 Q2	$1K	Hold	15	–	–	﹤0.01%	772
2019 Q1	$0	Hold	15	–	–	﹤0.01%	922
2018 Q4	$0	Sell	15 -2	-12%	-$268	﹤0.01%	925
2018 Q3	$2K	Sell	17 -67	-80%	-$10.2K	﹤0.01%	637
2018 Q2	$12K	Buy	84 +3	+4%	+$453	0.01%	437
2018 Q1	$9K	Buy	81 +17	+27%	+$2.5K	0.01%	447
2017 Q4	$7K	Buy	+64	New	+$8.46K	0.01%	504

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Avestar Capital's LH Position: Q3 2019 in Review

Avestar Capital sold out of Labcorp (LH) in Q3 2019, closing a stake of 15 shares — an estimated $1K sold.

Avestar Capital first reported a position in LH in Q4 2017 and held it in 7 quarters. The position peaked at $12K in Q2 2018. 739 funds tracked by Wall St. Rank hold LH as of Q3 2019.

Avestar Capital reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
Avestar Capital sold 15 Labcorp shares in Q3 2019, an estimated $1K.
Avestar Capital first reported a position in Labcorp in Q4 2017 and held it in 7 quarters.
Avestar Capital's Labcorp position peaked at $12K in Q2 2018.
739 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.